Feb 10 (Reuters)-
D.Western Therapeutics Institute Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 469 mln 427 mln 400 mln
(+9.8 pct) (+4.0 pct) (-14.9 pct)
Operating loss 1.17 loss 735 mln
Recurring loss 1.18 loss 728 mln loss 590 mln
Net loss 1.34 loss 853 mln loss 590 mln
EPS loss 38.15 yen loss 26.85 yen loss 13.78 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T